Inside BENEO’s new pulse plant: pioneering sustainable protein from faba beans
This latest funding round follows the company’s earlier success in securing its pre-seed round from Goodwater Capital, Brinc, IIMA Ventures, and Stanford Angels, among others
Sova Health, India’s pioneering full-stack Gut Health Company, announced the successful closing of its $1 million seed round. The investment was jointly led by global early-stage VC Antler, Accelerating Asia from Singapore, Practical VC from the US, and VC Grid & Venture Catalysts from India. The round also saw participation from Quadrant Consumer Products, Midas Capital (Baheti Family Office), and marquee angel investors.
This latest funding round follows the company’s earlier success in securing its pre-seed round from Goodwater Capital, Brinc, IIMA Ventures, and Stanford Angels, among others.
Sova Health will use the new investment to fuel the company’s growth initiatives across three key areas:
Product Development- the funding will support further research and development of a diverse range of gut health products, with a robust roadmap of over 25 products over the next one year.
Team Expansion: Sova plans to onboard team members to spearhead growth strategies and drive product development.
Market Expansion: The company aims to penetrate offline distribution channels and explore global markets, expanding its reach beyond its current online presence.
Tanveer Singh, Co-Founder and CEO, Sova Health said, “This investment marks a significant milestone for us as we continue to expand our product portfolio and reach. We are grateful for the support of our investors and look forward to leveraging this capital to drive innovation and make a positive impact in the gut health space. It’s still Day 0 in our mission to add a billion healthy years to the world.”